Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
The DOJ said in a court filing this month that Biomet breached a 2012 deferred prosecution agreement “based on conduct in Brazil and Mexico.”
A status report filed in federal court in Washington, D.C.… Continue Reading
Job Title: Compliance Counsel, Investigations (APAC)
Employer: Zimmer Biomet
Location: Singapore
Description
The Compliance Counsel, Investigations position for the Asia Pacific (APAC) region will be responsible for conducting confidential internal investigations on behalf of Zimmer Biomet.… Continue Reading
Orthopedic device maker Zimmer Biomet Holdings Inc. said in a securities filing Friday the DOJ and SEC are still investigating possible FCPA violations in Brazil and Mexico.
“These matters remain under investigation by the DOJ and the SEC,” Zimmer Biomet said Friday.… Continue Reading
Job Title: Compliance Counsel, Investigations
Employer: Zimmer Biomet
Location: Washington D.C.
Job Summary
The Compliance Counsel, Investigations will be responsible for conducting confidential internal investigations on behalf of Zimmer Biomet. This position is based in Washington, D.C.,… Continue Reading
The SEC said Thursday that medical device and equipment maker Stryker Corporation will pay $13.2 million to resolve FCPA violations.
Michigan-based Stryker bribed doctors and administrators at government controlled hospitals in Argentina, Greece, Mexico, Poland, and Romania, the SEC said.… Continue Reading
Minnesota-based Medtronic Inc. won a double declination following an FCPA probe that lasted more than five years. The medical device maker said it received word in June from the DOJ and SEC that they won’t pursue enforcement actions.… Continue Reading
It was a quiet start to the year, with just one stealth enforcement action by the SEC that didn’t mentioned the FCPA by name, and none by the DOJ.
So the feds’ go-slow enforcement trend continues.… Continue Reading
Following a five-year investigation into the overseas marketing and sales practices of medical device makers, the DOJ and SEC won’t bring any FCPA enforcement against one of the targeted companies, Zimmer Holdings Inc.… Continue Reading
Medical device maker Zimmer Holdings, Inc. said in an SEC filing yesterday that it can’t predict the outcome of DOJ and SEC investigations into its overseas sales practices.
The enforcement agencies opened their investigations in 2007.… Continue Reading
U.K.-based medical device maker Smith & Nephew plc agreed to pay $22.2 million to settle Foreign Corrupt Practices Act offenses committed by its U.S. and German subsidiaries.
The company admitted bribing government-employed doctors in Greece for more than a decade to win business.… Continue Reading
Johnson & Johnson will pay a $21.4 million penalty to resolve criminal FCPA charges with the DOJ and $48.6 million in disgorgement and prejudgment interest to settle the SEC’s civil charges.… Continue Reading
